Related Experiment Video
Updated: Jan 1, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Mixing studies for lupus anticoagulant: mostly no, sometimes yes
1Department of Haematology, Specialist Haemostasis Unit, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.
Mixing tests in lupus anticoagulant (LA) detection can yield false negatives, potentially leading to missed diagnoses. Integrated testing offers a more reliable alternative for identifying LA, with mixing tests playing a supplementary role.
Area of Science:
- Clinical Chemistry
- Hematology
- Immunology
Background:
- Mixing tests are a traditional component of lupus anticoagulant (LA) assays.
- False-negative results from mixing tests can lead to missed LA diagnoses and impact patient management.
- Factors like dilution effect and reagent variability challenge the reliability of traditional mixing tests.
Purpose of the Study:
- To evaluate the reliability of traditional mixing tests in lupus anticoagulant (LA) detection.
- To explore the implications of false-negative mixing tests in LA diagnosis.
- To introduce integrated testing as a potentially more accurate method for LA detection.
Main Methods:
- Review of studies on lupus anticoagulant (LA) testing methodologies.
- Analysis of factors contributing to false-negative mixing tests.
- Comparison of traditional mixing tests with integrated testing approaches.
Main Results:
- Studies show significant frequencies of false-negative mixing tests in LA assays.
- Several factors, including dilution effects and reagent differences, compromise mixing test reliability.
- Integrated testing demonstrates a reliable alternative for LA detection.
Conclusions:
- The reliability of traditional mixing tests for lupus anticoagulant (LA) diagnosis is questionable.
- Integrated testing provides a more dependable approach to LA detection.
- Mixing tests retain a supplementary role in specific diagnostic scenarios.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

